Results summary | View all lists in L2L MDB | View all genes in H02A.profile.d50 |
Down-regulated in fibroblasts following infection with human cytomegalovirus (at least 3-fold, with Affymetrix change call, in at least two consectutive timepoints) enrichment: 3.38-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
207980_S_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
212593_S_AT | PDCD4 | G | R | programmed cell death 4 (neoplastic transformation inhibitor) | |||||||||
203438_AT | STC2 | C | S | stanniocalcin 2 | |||||||||
202437_S_AT | CYP1B1 | E | cytochrome P450, family 1, subfamily B, polypeptide 1 | ||||||||||
202436_S_AT | CYP1B1 | E | cytochrome P450, family 1, subfamily B, polypeptide 1 | ||||||||||
202435_S_AT | CYP1B1 | E | cytochrome P450, family 1, subfamily B, polypeptide 1 | ||||||||||
217996_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 |